Trial flowchart.
CKD, diabetes
CORONARY DISEASE, HYPERTENSION, DYSLIPIDEMIA, DIABETES
Our population was at high cardiovascular risk, 58.2% of patients were smokers, 60.9% had hypertension, 51.8% had diabetes, 81% had dyslipidemia, 7.3% had moderate CKD, and 34.5% had a history of coronary disease. Sixty-six percent of our patients had at least three cardiovascular risk factors. All patients had been receiving atorvastatin for more than one month before the coronary catheterization (58.2% received 40 mg of atorvastatin, 7.3% received 20 mg of atorvastatin, and 34.5% received 10 mg of atorvastatin).The baseline clinical characteristics and laboratory results are summarized in Tables 